Literature DB >> 21950323

Themed section: molecular pharmacology of GPCRs.

R J Summers1.   

Abstract

As our knowledge and understanding of the way in which GPCRs operate continues to grow rapidly, many new opportunities are emerging to develop novel therapeutic agents. This themed issue of the British Journal of Pharmacology contains a series of papers that cover recent developments and identify approaches that may help determine future directions. Many of these papers contain material that was presented at the 6th International Molecular Pharmacology of G Protein-Coupled Receptors meeting held at the Monash Institute of Pharmaceutical Sciences in Melbourne Australia in late 2010.
© 2011 The Author. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Mesh:

Substances:

Year:  2012        PMID: 21950323      PMCID: PMC3372816          DOI: 10.1111/j.1476-5381.2011.01679.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

Review 1.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.

Authors:  Michelle L Halls
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 4.  GPCR expression in tissues and cells: are the optimal receptors being used as drug targets?

Authors:  P A Insel; A Snead; F Murray; L Zhang; H Yokouchi; T Katakia; O Kwon; D Dimucci; A Wilderman
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Lifting the lid on GPCRs: the role of extracellular loops.

Authors:  M Wheatley; D Wootten; M T Conner; J Simms; R Kendrick; R T Logan; D R Poyner; J Barwell
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 6.  Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.

Authors:  Vu C Dang; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 7.  The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.

Authors:  Marc Laburthe; Thierry Voisin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 8.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 9.  Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors.

Authors:  Alice Cavanaugh; Ying Huang; Gerda E Breitwieser
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

  9 in total
  1 in total

Review 1.  RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer.

Authors:  Thatchawan Thanasupawat; Aleksandra Glogowska; Maxwell Burg; G William Wong; Cuong Hoang-Vu; Sabine Hombach-Klonisch; Thomas Klonisch
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-13       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.